BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Vitamin E
,
rs7903146
,
PRKCA
,
calcium channel activity
,
Inflammatory disorder
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NBN
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
L1000 CMAP - Neuroblastoma SH-SY5Y cells with shRNA-mediated gene knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Uterine carcinosarcoma associated with a germline nibrin (NBN) mutation.
Scanning the latent phases and superconductivity in the Nb-Pb system at high pressure.
Expression of the Mre11-Rad50-Nbs1 complex in cisplatin nephrotoxicity.
Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With …
Association of the nibrin gene (NBN) variants with breast cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Neuroscience-based Nomenclature (NbN) as a Teaching Tool
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer
Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumor…
A Study to Evaluate Rucaparib in Patients With Solid Tumors and With Deleterious Mutations in HRR Ge…
Olaparib In Metastatic Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ